| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapy
|
Chiara, Silvana
|
|
1998
|
42 |
Suppl 1 |
p. 336-340
|
article
|
| 2 |
Allosteric effectors of hemoglobin as modulators of chemotherapy and radiation therapy in vitro and in vivo
|
Teicher, Beverly A.
|
|
1998
|
42 |
Suppl 1 |
p. 24-30
|
article
|
| 3 |
A new analogue of 10-deazaaminopterin with markedly enhanced curative effects against human tumor xenografts in mice
|
Sirotnak, F. M.
|
|
1998
|
42 |
Suppl 1 |
p. 313-318
|
article
|
| 4 |
Antihelicase action of CI-958, a new drug for prostate cancer
|
Lun, Lapman
|
|
1998
|
42 |
Suppl 1 |
p. 447-453
|
article
|
| 5 |
Circumvention of P-glycoprotein-mediated multidrug resistance by S16020-2: kinetics of uptake and efflux in sensitive and resistant cell lines
|
Pierré, A.
|
|
1998
|
42 |
Suppl 1 |
p. 454-460
|
article
|
| 6 |
Clinical pharmacology of UCN-01: Initial observations and comparison to preclinical models
|
Sausville, Edward A.
|
|
1998
|
42 |
Suppl 1 |
p. S54-S59
|
article
|
| 7 |
Clinical pharmacology of UCN-01: Initial observations and comparison to preclinical models
|
Sausville, Edward A.
|
|
|
42 |
Suppl 1 |
p. S54-S59
|
article
|
| 8 |
Cytostatic and apoptotic effects of paclitaxel in human breast tumors
|
Gan, Yuebo
|
|
1998
|
42 |
Suppl 1 |
p. 177-182
|
article
|
| 9 |
Cytostatic and apoptotic effects of paclitaxel in human breast tumors
|
Gan, Yuebo
|
|
1998
|
42 |
Suppl 1 |
p. 177-182
|
article
|
| 10 |
Determination of the cytoprotective agent WR-2721 (Amifostine, Ethyol®) and its metabolites in human blood using monobromobimane fluorescent labeling and high-performance liquid chromatography
|
Souid, Abdul-Kader
|
|
1998
|
42 |
Suppl 1 |
p. 400-406
|
article
|
| 11 |
Effect of cytokines on the toxicity of cytostatic drugs to normal bone marrow cells in vitro
|
Sundman-Engberg, Britt
|
|
1998
|
42 |
Suppl 1 |
p. 255-260
|
article
|
| 12 |
Effect of cytokines on the toxicity of cytostatic drugs to normal bone marrow cells in vitro
|
Sundman-Engberg, Britt
|
|
1998
|
42 |
Suppl 1 |
p. 255-260
|
article
|
| 13 |
Effects of demographic variables on vorozole pharmacokinetics in healthy volunteers and in breast cancer patients
|
Piotrovsky, Vladimir K.
|
|
1998
|
42 |
Suppl 1 |
p. 221-228
|
article
|
| 14 |
Effects of demographic variables on vorozole pharmacokinetics in healthy volunteers and in breast cancer patients
|
Piotrovsky, Vladimir K.
|
|
1998
|
42 |
Suppl 1 |
p. 221-228
|
article
|
| 15 |
Evaluation of the linearity of docetaxel pharmacokinetics
|
McLeod, Howard L.
|
|
1998
|
42 |
Suppl 1 |
p. 155-159
|
article
|
| 16 |
FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome
|
Naoe, Yoshinori
|
|
1998
|
42 |
Suppl 1 |
p. 31-36
|
article
|
| 17 |
Fluorescence methods to assess multidrug resistance in individual cells
|
Nelson, Eric J.
|
|
1998
|
42 |
Suppl 1 |
p. 292-299
|
article
|
| 18 |
Growth-inhibitory effects of the synthetic retinoid CD437 against ovarian carcinoma models in vitro and in vivo
|
Langdon, Simon P.
|
|
1998
|
42 |
Suppl 1 |
p. 429-432
|
article
|
| 19 |
Hematotoxicity on human bone marrow- and umbilical cord blood-derived progenitor cells and in vitro therapeutic index of methoxymorpholinyldoxorubicin and its metabolites
|
Ghielmini, Michele
|
|
1998
|
42 |
Suppl 1 |
p. 235-240
|
article
|
| 20 |
Hematotoxicity on human bone marrow- and umbilical cord blood-derived progenitor cells and in vitro therapeutic index of methoxymorpholinyldoxorubicin and its metabolites
|
Ghielmini, Michele
|
|
1998
|
42 |
Suppl 1 |
p. 235-240
|
article
|
| 21 |
High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically
|
Lara Jr., Primo N.
|
|
1998
|
42 |
Suppl 1 |
p. 504-508
|
article
|
| 22 |
Inhibition of intestinal microflora β-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats
|
Takasuna, Kiyoshi
|
|
1998
|
42 |
Suppl 1 |
p. 280-286
|
article
|
| 23 |
Irinotecan (CPT-11) in combination with weekly administration of cisplatin (CDDP) for non-small-cell lung cancer
|
Kobayashi, Kunihiko
|
|
1998
|
42 |
Suppl 1 |
p. 53-58
|
article
|
| 24 |
Jasplakinolide: interaction with radiation and hyperthermia in human prostate carcinoma and Lewis lung carcinoma
|
Takeuchi, Hideya
|
|
1998
|
42 |
Suppl 1 |
p. 491-496
|
article
|
| 25 |
Pharmacokinetics, antifolate activity and tissue distribution of PT523 in SCC VII tumor-bearing mice
|
Wright, Joel E.
|
|
1998
|
42 |
Suppl 1 |
p. 300-306
|
article
|
| 26 |
Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration
|
Marzolini, Catia
|
|
1998
|
42 |
Suppl 1 |
p. 433-440
|
article
|
| 27 |
Pharmacokinetic study of low- versus high-dose medroxyprogesterone acetate (MPA) in women
|
Ohtsu, Tomoko
|
|
1998
|
42 |
Suppl 1 |
p. 1-8
|
article
|
| 28 |
Phase I clinical and pharmacokinetic study of oral 9-aminocamptothecin (NSC-603071)
|
Mani, Sridhar
|
|
1998
|
42 |
Suppl 1 |
p. 84-87
|
article
|
| 29 |
Phase II study of Temodal in the treatment of patients with advanced nasopharyngeal carcinoma
|
Chan, Anthony T. C.
|
|
1998
|
42 |
Suppl 1 |
p. 247-249
|
article
|
| 30 |
Phase II study of Temodal in the treatment of patients with advanced nasopharyngeal carcinoma
|
Chan, Anthony T. C.
|
|
1998
|
42 |
Suppl 1 |
p. 247-249
|
article
|
| 31 |
Phase I study of E7010
|
Yamamoto, Kaichiro
|
|
1998
|
42 |
Suppl 1 |
p. 127-134
|
article
|
| 32 |
Phase I study of oral JM216 given twice daily
|
Beale, P.
|
|
1998
|
42 |
Suppl 1 |
p. 142-148
|
article
|
| 33 |
Potent and broad antitumor effects of DX-8951f, a water-soluble camptothecin derivative, against various human tumors xenografted in nude mice
|
Kumazawa, Eiji
|
|
1998
|
42 |
Suppl 1 |
p. 210-220
|
article
|
| 34 |
Potent and broad antitumor effects of DX-8951f, a water-soluble camptothecin derivative, against various human tumors xenografted in nude mice
|
Kumazawa, Eiji
|
|
1998
|
42 |
Suppl 1 |
p. 210-220
|
article
|
| 35 |
Preclinical pharmacology, toxicology and efficacy of sphingomyelin/cholesterol liposomal vincristine for therapeutic treatment of cancer
|
Webb, Murray S.
|
|
1998
|
42 |
Suppl 1 |
p. 461-470
|
article
|
| 36 |
Prevention of apomorphine- or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphine
|
Foss, Joseph F.
|
|
1998
|
42 |
Suppl 1 |
p. 287-291
|
article
|
| 37 |
Prophylactic intravesical instillation chemotherapy against recurrence after a transurethral resection of superficial bladder cancer: a randomized controlled trial of doxorubicin plus verapamil versus doxorubicin alone
|
Naito, Seiji
|
|
1998
|
42 |
Suppl 1 |
p. 367-372
|
article
|
| 38 |
Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines
|
Civoli, Francesca
|
|
1998
|
42 |
Suppl 1 |
p. 319-326
|
article
|
| 39 |
Renal toxicity of the anticancer drug fostriecin
|
de Jong, Robert S.
|
|
1998
|
42 |
Suppl 1 |
p. 160-164
|
article
|
| 40 |
Reversal of multidrug resistance by a liposome-MDR1 ribozyme complex
|
Masuda, Yoshihiro
|
|
1998
|
42 |
Suppl 1 |
p. 9-16
|
article
|
| 41 |
Risk of severe acute hypersensitivity reactions after rapid paclitaxel infusion of less than 1-h duration
|
Tsavaris, Nicolas B.
|
|
1998
|
42 |
Suppl 1 |
p. 509-511
|
article
|
| 42 |
Serum and urine levels of tamoxifen and its metabolites in patients with advanced breast cancer after a loading dose and at steady-state levels
|
de Vos, Dick
|
|
1998
|
42 |
Suppl 1 |
p. 512-514
|
article
|
| 43 |
Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer
|
Calvo, Rosario
|
|
1998
|
42 |
Suppl 1 |
p. 418-422
|
article
|
| 44 |
The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin
|
Schulte, Theodor W.
|
|
1998
|
42 |
Suppl 1 |
p. 273-279
|
article
|
| 45 |
The influence of relative body weight on toxicity of combination chemotherapy with cisplatin and etoposide
|
Miya, Toshimichi
|
|
1998
|
42 |
Suppl 1 |
p. 386-390
|
article
|
| 46 |
Therapeutic efficacy of vinorelbine against pediatric and adult central nervous system tumors
|
Hanley, Matthew L.
|
|
1998
|
42 |
Suppl 1 |
p. 479-482
|
article
|
| 47 |
Toxicity of cytostatic drugs to normal bone marrow cells in vitro
|
Sundman-Engberg, Britt
|
|
1998
|
42 |
Suppl 1 |
p. 17-23
|
article
|
| 48 |
Yeast cells expressing differential levels of human or yeast DNA topoisomerase II: a potent tool for identification and characterization of topoisomerase II-targeting antitumour agents
|
van Hille, Benoît
|
|
1998
|
42 |
Suppl 1 |
p. 345-356
|
article
|
Journal description